Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002450265 | SCV002732579 | pathogenic | Hereditary cancer-predisposing syndrome | 2020-06-02 | criteria provided, single submitter | clinical testing | The c.2402delA pathogenic mutation, located in coding exon 14 of the MSH2 gene, results from a deletion of one nucleotide at nucleotide position 2402, causing a translational frameshift with a predicted alternate stop codon (p.H801Lfs*11). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |